• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌手术后的胰酶替代疗法:患者自我管理的探索

Pancreatic enzyme replacement therapy following surgery for pancreatic cancer: An exploration of patient self-management.

作者信息

Dunleavy Lisa, Al-Mukhtar Ahmed, Halliday Vanessa

机构信息

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

出版信息

Clin Nutr ESPEN. 2018 Aug;26:97-103. doi: 10.1016/j.clnesp.2018.04.007. Epub 2018 May 4.

DOI:10.1016/j.clnesp.2018.04.007
PMID:29908691
Abstract

BACKGROUND

For those diagnosed with pancreatic cancer, ill-addressed pancreatic exocrine insufficiency (PEI) following surgery can result in malnutrition related complications that may impact on predict mortality and morbidity. The use of pancreatic enzyme replacement therapy (PERT) is recommended and often demands a degree of patient self-management. Understanding more about how this treatment is managed is fundamental to optimising care.

OBJECTIVE

This study aimed to explore patient self-management of PERT following surgery for pancreatic cancer.

METHODS

Semi-structured interviews were conducted with nine participants. Eligible participants included adult patients who had undergone surgery for a malignancy in the pancreatic region and were prescribed PERT post-operatively. Inductive thematic analysis was used to analyse our findings.

RESULTS

Data analysis revealed three overarching themes; the role of professional support, factors influencing decisions to use PERT in symptom management and the challenges of socializing. The difficulties negotiated by participants were considerable as they struggled with the complexities of PERT. Symptom management and subsequently reported physical repercussions and undesirable social implications were problematic. Professional support was largely inconsistent and relinquished prematurely following discharge. Consequently, this impacted on how PERT was self-managed.

CONCLUSION

Enabling patients to appropriately self-manage PERT may lessen the post-treatment burden. Our findings suggest that support should continue throughout the recovery phase and should address the patient's 'self-management journey'. Intervention by healthcare professionals, such as a specialist dietitian is likely to be beneficial. Furthermore there are focal issues, primarily explicit education and appropriately timed information that require consideration by those developing and delivering services.

摘要

背景

对于那些被诊断为胰腺癌的患者,术后胰腺外分泌功能不全(PEI)处理不当会导致与营养不良相关的并发症,这可能会影响死亡率和发病率的预测。推荐使用胰酶替代疗法(PERT),且通常需要患者进行一定程度的自我管理。更多地了解这种治疗方法的管理方式对于优化护理至关重要。

目的

本研究旨在探讨胰腺癌手术后患者对PERT的自我管理情况。

方法

对9名参与者进行了半结构化访谈。符合条件的参与者包括在胰腺区域进行过恶性肿瘤手术且术后被开具PERT的成年患者。采用归纳主题分析法对研究结果进行分析。

结果

数据分析揭示了三个总体主题;专业支持的作用、影响在症状管理中使用PERT的决策因素以及社交方面的挑战。参与者所面临的困难相当大,因为他们在应对PERT的复杂性时遇到了困难。症状管理以及随后报告的身体影响和不良社会影响都存在问题。专业支持在很大程度上不一致,出院后过早停止。因此,这影响了PERT的自我管理方式。

结论

使患者能够适当地自我管理PERT可能会减轻治疗后的负担。我们的研究结果表明,在整个康复阶段都应持续提供支持,并应关注患者的“自我管理过程”。医疗保健专业人员的干预,如专科营养师,可能会有所帮助。此外,还有一些重点问题,主要是明确的教育和适时的信息,需要服务的开发者和提供者加以考虑。

相似文献

1
Pancreatic enzyme replacement therapy following surgery for pancreatic cancer: An exploration of patient self-management.胰腺癌手术后的胰酶替代疗法:患者自我管理的探索
Clin Nutr ESPEN. 2018 Aug;26:97-103. doi: 10.1016/j.clnesp.2018.04.007. Epub 2018 May 4.
2
Exocrine pancreatic insufficiency following esophagectomy.食管切除术后的外分泌胰腺功能不全。
Dis Esophagus. 2013 Aug;26(6):594-7. doi: 10.1111/dote.12004. Epub 2012 Nov 30.
3
Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.治疗胰腺外分泌功能不全对不可切除胰腺癌患者生存的影响:一项回顾性分析。
BMC Cancer. 2018 May 5;18(1):534. doi: 10.1186/s12885-018-4439-x.
4
Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy.胰腺外分泌替代疗法与壶腹周围恶性肿瘤胰十二指肠切除术后生存率提高相关。
HPB (Oxford). 2017 Oct;19(10):859-867. doi: 10.1016/j.hpb.2017.05.009. Epub 2017 Jul 12.
5
Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients.胰腺癌患者胰腺酶替代治疗的合理应用频率和症状反应。
Pancreas. 2019 Jul;48(6):780-786. doi: 10.1097/MPA.0000000000001330.
6
The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent.在美国,慢性胰腺炎和胰腺癌患者使用胰腺酶替代治疗的情况并不常见且不一致。
Aliment Pharmacol Ther. 2020 May;51(10):958-967. doi: 10.1111/apt.15698. Epub 2020 Apr 6.
7
Pancreatic Enzyme Replacement Therapy for Patients Diagnosed With Pancreaticobiliary Cancer: Validation of an Algorithm for Dose Escalation and Management.用于诊断为胰胆管癌的患者的胰腺酶替代治疗:剂量递增和管理算法的验证。
Pancreas. 2021 Oct 1;50(9):1254-1259. doi: 10.1097/MPA.0000000000001906.
8
Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.酶替代疗法改善胰腺癌患者的生存:一项基于人群的研究结果。
Pancreatology. 2019 Jan;19(1):114-121. doi: 10.1016/j.pan.2018.10.010. Epub 2018 Oct 24.
9
Dose optimization of pancreatic enzyme replacement therapy is essential to mitigate muscle loss in patients with advanced pancreatic cancer and exocrine pancreatic insufficiency.优化胰腺酶替代治疗的剂量对于减轻晚期胰腺癌和胰腺外分泌功能不全患者的肌肉损失至关重要。
Clin Nutr. 2024 Aug;43(8):1900-1906. doi: 10.1016/j.clnu.2024.06.037. Epub 2024 Jul 4.
10
Perioperative management of pancreatic exocrine insufficiency-evidence-based proposal for a paradigm shift in pancreatic surgery.胰腺外分泌功能不全的围手术期管理——胰腺手术中范式转变的循证建议。
HPB (Oxford). 2024 Jan;26(1):117-124. doi: 10.1016/j.hpb.2023.09.003. Epub 2023 Sep 9.

引用本文的文献

1
Supportive Care Needs and Related Interventions in Patients with Pancreatic Cancer and Their Informal Caregivers: A Scoping Review.胰腺癌患者及其非正式照护者的支持性护理需求及相关干预措施:一项范围综述
J Gastrointest Cancer. 2025 Apr 16;56(1):98. doi: 10.1007/s12029-025-01218-8.
2
European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendations.欧洲胰腺外分泌功能不全诊断与治疗指南:UEG、EPC、EDS、ESPEN、ESPGHAN、ESDO和ESPCG基于证据的建议。
United European Gastroenterol J. 2025 Feb;13(1):125-172. doi: 10.1002/ueg2.12674. Epub 2024 Dec 5.
3
Challenges in Diagnosis and Treatment of Pancreatic Exocrine Insufficiency among Patients with Pancreatic Ductal Adenocarcinoma.
胰腺导管腺癌患者胰腺外分泌功能不全的诊断与治疗挑战
Cancers (Basel). 2023 Feb 20;15(4):1331. doi: 10.3390/cancers15041331.
4
Pilot trial of remote monitoring to prevent malnutrition after hepatopancreatobiliary surgery.肝胰胆手术后远程监测预防营养不良的试点试验
BMC Nutr. 2021 Dec 9;7(1):82. doi: 10.1186/s40795-021-00487-3.
5
Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines.胰腺外分泌功能不全管理共识:英国实用指南
BMJ Open Gastroenterol. 2021 Jun;8(1). doi: 10.1136/bmjgast-2021-000643.